Spain's health system faces critical shortage of key cancer drug, Tronoxal

diariodeavisos.elespanol.com (Spanish)

Spain's health system faces a critical shortage of Tronoxal, a key cancer drug, with no supply expected until April. The Spanish Agency of Medicines and Medical Devices (AEMPS) is urgently sourcing foreign medication as the manufacturer, Baxter S.L., failed to notify them of a production halt. The drug, ifosfamide, is vital for treating sarcomas and lymphomas. AEMPS has prioritized remaining stock for critical cases and advised alternative treatments for others.


With a significance score of 2.1, this news ranks in the top 25% of today's 27650 analyzed articles.

Get summaries of news with significance over 5.5 (usually ~10 stories per week). Read by 10,000+ subscribers:


Spain's health system faces critical shortage of key cancer drug, Tronoxal | News Minimalist